Cramer: The Market Welcomes the Jobs Number

Editor's Note: This article was originally published at 10:41 a.m. EDT on Real Money on June 7. To see Jim Cramer's latest commentary as it's published, sign up for a free trial of Real Money.

NEW YORK ( Real Money) -- Right back to the generals. Right back to biotech -- Gilead ( GILD), Celgene ( CELG), Biogen Idec ( BIIB) and Regeneron ( REGN). Right back to aerospace, meaning Boeing ( BA) and United Technologies ( UTX). Right back to Home Depot ( HD).

It's like nothing ever happened.

Rates?

Employment?

How about, jobs number in line, big bad event is over, and on to the next?

Look, it was a big number, but only if it varied from the consensus. There are tons of people who sold stocks ahead, and not many who bought.

So those who sold because they feared a big down day and those who were waiting for a price break now think that it's passed, and they are in.

I think that Thursday may have been some sort of whoosh bottom where everyone who wanted to sell got their chance.

It looks like we've averted the worst case -- not bad, not bad at all.

Action Alerts PLUS, which Cramer co-manages as a charitable trust, has no positions in the stocks mentioned.

If you liked this article you might like

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Stock Market Drop Not Seen Dampening Healthcare Deal Activity

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Why Investors Shouldn't Worry About Trump's Tough Talk on Drug Prices

Centene, LabCorp Among Healthcare Stock Gainers

Centene, LabCorp Among Healthcare Stock Gainers

A Regular Winning Trade Becomes Roadkill in Market Meltdown

A Regular Winning Trade Becomes Roadkill in Market Meltdown

These 2 Biotech Stocks Still Have Upside

These 2 Biotech Stocks Still Have Upside